Top Dow Dividend Stocks To Watch For 2015

It was a banner 12 months from Dec. 31, 2012, through Dec. 31, 2013, for the S&P 500 Index, which posted a total return–capital gain or loss plus dividends paid–of 32.4 percent.

This follows the 16 percent total return for 2012. Note that only four of the 16 times since 1928 the market has performed as well as it did in 2012 has it followed up with a year that exceed the prior total return.

Looking at the subgroups that comprise the world’s most-watched equity benchmark, Consumer Discretionary led the way with a 43.1 percent total return. Health Care was close behind at 41.5 percent.

Industrials and Financials also pulled the broader average higher, with gains of 40.6 percent and 35.6 percent, respectively.

Consumer Staples (26.1 percent), Materials (25.6 percent), Energy (25.1 percent) and Technology (18.8 percent) posted below-average but respectable performances.

Top Dow Dividend Stocks To Watch For 2015: Sector Spdr Trust Sbi (XLI)

Industrial Select Sector SPDR Fund (the Fund) seeks to provide investment results that correspond to the price and yield performance of the Industrial Select Sector of the S&P 500 Index (the Index). The Index includes companies from industries, such as aerospace and defense, building products, construction and engineering, electrical equipment, conglomerates, machinery, commercial services and supplies.

The Fund utilizes a passive or indexing investment approach to invest in a portfolio of stocks that seek to replicate the Index. The Fund’s investment advisor is SSgA Funds Management, Inc.

Advisors’ Opinion:

  • [By Ben Levisohn]

    The Consumer Discretionary Select Sector SPDR (XLY) has dropped 1.1% to $60.39, while the Financial Select Sector SPDR(XLF) is off 0.9% at $20.23.  Hardest hit is the Utilities Select Sector SPDR (XLU), which has dropped 1.6% to $37.32, while the Industrial Select Sector SPDR ETF (XLI) has fallen 1% to $46.49. The Technology Select Sector SPDR (XLK) is the top performer: It’s down 0.5% at $32.39.

  • [By Selena Maranjian]

    Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you’d like to add some industrial stocks to your portfolio, the Industrial Select Sector SPDR ETF (NYSEMKT: XLI  ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this ETF to invest in lots of them simultaneously.

    The basics
    ETFs often sport lower expense ratios than their mutual fund cousins. The SPDR ETF’s expense ratio — its annual fee — is a very low 0.18%, and it recently yielded about 2%.

    This ETF has performed well, outstripping the world market over the past three, five, and 10 years. As with most investments, of course, we can’t expect outstanding performances in every quarter or year. Investors with conviction need to wait for their holdings to deliver.

  • [By Ben Levisohn]

    The selling today has being driven by the industrial sector–the Industrial Select Sector SPDR (XLI) has dropped 1.5% to $45.79–and defense stocks are getting hammered. Textron (TXT) has fallen 3% to $26.82, while Northrop Grumman (NOC) has declined 2.5% to $92.82. Not a surprise as reports of government contracts being held up and orders delayed make the rounds.

Top Dow Dividend Stocks To Watch For 2015: Glu Mobile Inc.(GLUU)

Glu Mobile Inc. designs, markets, and sells mobile games worldwide. It develops original games based on its intellectual property comprising Big Time Gangsta?, Blood & Glory, Bug Village, Contract Killer, Contract Killer: Zombies, Eternity Warriors, Frontline Commando, Gun Bros, Men vs. Machines, Stardom: The A-List, Super K.O. Boxing and Toyshop Adventures. The company also develops games based on licensed intellectual property consisting of Build-a-lot, Call of Duty, Deer Hunter, DJ Hero, Guitar Hero, Family Feud, Family Guy, Lord of the Rings, Paperboy, The Price Is Right, Transformers, Who Wants to Be a Millionaire?, and World Series of Poker. It offers a portfolio of action/adventure and casual games to smartphones and tablet devices users through direct-to-consumer digital storefronts, as well as to feature phone users served by wireless carriers and other distributors. The company was formerly known as Sorrent, Inc. and changed its name to Glu Mobile Inc. in May 20 05. Glu Mobile Inc. was incorporated in 2001 and is headquartered in San Francisco, California.

Advisors’ Opinion:

  • [By Paul Ausick]

    Glu Mobile Inc. (NASDAQ: GLUU) held its IPO in May of 2007 and raised $84 million on the sale of 7.3 million shares at a price of $11.50. Like Zynga, shares peaked around $14 within a few months, and the stock trades today at around $5 a share, up from near $2 a share last September. The shares have gained about 33% in the past three weeks, mostly due to the company’s freemium business model, where the games are free to play and in-app transactions of $1.99 or less keep players opening their wallets.

  • [By John Kell]

    Glu Mobile Inc.’s(GLUU) fourth-quarter loss narrowed from the previous year, as the mobile-game maker reported strong success for “Deer Hunter 2014.” Results for the period were stronger than expected and Glu Mobile issued outlook targets that exceeded Wall Street’s expectations. Shares surged 21% to $4.67 premarket.

  • [By Lisa Levin]

    Glu Mobile (NASDAQ: GLUU) dipped 10.29% to $3.40 on Q3 results.

    Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets

Top Dow Dividend Stocks To Watch For 2015: Abbott Laboratories(ABT)

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. The company offers adult and pediatric pharmaceuticals for rheumatoid and psoriatic arthritis, ankylosing spondylitis, psoriasis, and Crohn’s disease; dyslipidemia; HIV infection; prostate cancer, endometriosis and central precocious puberty, and anemia caused by uterine fibroids; respiratory syncytial virus; adult males who have low or no testosterone; secondary hyperparathyroidism; hypothyroidism; and pancreatic exocrine insufficiency, as well as anesthesia products. It also provides diagnostic products, such as immunoassay systems; chemistry systems; assays used for screening and/or diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, physiological, and infectious diseases; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infections agents; genomic-b ased tests; hematology systems and reagents; and point-of-care diagnostic systems and tests for blood analysis. In addition, the company offers a line of pediatric and adult nutritional products. Further, it provides coronary, endovascular, vessel closure, and structural heart devices, such as drug-eluting stent systems, coronary metallic stents, balloon dilatation products, coronary guidewires, vessel closure devices, carotid stent systems, percutaneous valve repair systems, and drug eluting bioresorbable vascular products. Additionally, the company provides blood glucose monitoring meters, test strips, data management software, and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, lasik surgery, contact lens, and dry eye products, as well as branded generic pharmaceutical products. Abbott primarily serves retailers, wholesalers, hospitals, and health care facilities. Abbott was founded in 1888 and is headquartered in Abbott Park, Illinois.

Advisors’ Opinion:

  • [By MONEYMORNING.COM]

    And it’s not just because you were able to cash in on our recommendation of Abbott Laboratories Inc. (NYSE: ABT), whose subsequent breakup into two companies has so far resulted in gains of 27% and 47%.

  • [By J. Royden Ward]

    Founded in 1888, Abbott Laboratories (ABT) is the leading provider of blood screening products used to detect pregnancy, heart disease, prostate cancer, hepatitis, HIV, sports doping, and other medical conditions.

Top Dow Dividend Stocks To Watch For 2015: TearLab Corporation(TEAR)

TearLab Corporation operates as an ophthalmic device company. It engages in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The company?s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab disposable and the TearLab pen, as well as provides a quantitative reading for the operator. TearLab Corporation markets its system through a network of distributors in North America, Europe, and Asia. The company, formerly known as OccuLogix, Inc., was founded in 1996 and is headquart ered in San Diego, California.

Advisors’ Opinion:

  • [By Seth Jayson]

    TearLab (Nasdaq: TEAR  ) reported earnings on May 13. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended March 31 (Q1), TearLab beat expectations on revenues and exceeded expectations on earnings per share.

  • [By Roberto Pedone]

    One potential earnings short-squeeze candidate is in-vitro diagnostic player TearLab (TEAR), which is set to release numbers on Tuesday after the market close. Wall Street analysts, on average, expect TearLab to report revenue of $3.51 million on a loss of 13 cents per share.

    This company has managed to top Wall Street estimates two times over the last four quarters, which is a bullish earnings trend. If TearLab can delve another beat, then shares could be setting up for a large move higher.

    The current short interest as a percentage of the float for TearLab is extremely high at 37.1%. That means that out of the 25.54 million shares in the tradable float, 8.59 million shares are sold short by the bears. This is a huge short interest on a stock with a very low tradable float. If the bulls get the earnings news they’re looking for, then shares of TEAR could easily explode higher post-earnings as the bears jump to cover some of their bets.

    From a technical perspective, TEAR is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strong for the last six months, with shares moving higher from its low of $5.26 to its recent high of $15.18 a share. During that uptrend, shares of TEAR have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of TEAR within range of triggering a major breakout trade post-earnings.

    If you’re bullish on TEAR, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $14.28 to its 52-week high at $15.18 a share with high volume. Look for volume on that move that registers near or above its three-month average action of 942,598 shares. If that breakout hits, then TEAR will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside

Top Dow Dividend Stocks To Watch For 2015: 1st Constitution Bancorp(NJ)

1st Constitution Bancorp operates as a bank holding company for 1st Constitution Bank that provides community banking services to corporations, individuals, partnerships, and other community organizations in the central and northeastern New Jersey area. It offers various deposit products, including noninterest bearing demand deposits, interest bearing demand deposits, savings deposits, and time deposits, as well as certificates of deposit, and money market and NOW accounts. The company also provides a range of loan products comprising commercial loans for working capital, business expansion, and the purchase of equipment and machinery; construction loans to real estate developers for the acquisition, development and construction of residential subdivisions; residential consumer loans; term loans; lines of credit; loans secured by equipment and receivables; second mortgage home improvement loans; home equity lines of credit; and non-residential consumer loans for automobile s, recreation vehicles, and boats, as well as secured and unsecured personal loans, and deposit account secured loans. It provides its services through a network of 14 branches. The company was founded in 1989 and is based in Cranbury, New Jersey.

Advisors’ Opinion:

  • [By Mark Skousen]

    And that brings me to Nidec (NJ). Based in Kyoto, Japan, Nidec manufactures small- to mid-size motors, fan motors, and pivot assemblies used in dozens of IT products, as well as home appliances, automobiles, office equipment, and industrial machinery.

  • [By Monica Gerson]

    Nidec (NYSE: NJ) shares climbed 2.75% to $20.17. The volume of Nidec shares traded was 506% higher than normal. Nidec’s trailing-twelve-month revenue is $9.42 billion.

Top Dow Dividend Stocks To Watch For 2015: GenMark Diagnostics Inc.(GNMK)

GenMark Diagnostics, Inc. operates as a molecular diagnostics company primarily in the United States. It focuses on the development and commercialization of multiplexed molecular diagnostic testing systems for the detection and measurement of DNA and RNA targets used in the treatment of patients. The company?s products comprise eSensor XT-8 system, an automated molecular diagnostic system, which enable reference laboratories and hospitals to perform molecular diagnostic tests; and eSensor XT-8 Cartridge that utilizes a microfluidic system to accelerate target binding and enhance time to result. It also offers IVD tests, including eSensor cystic fibrosis genotyping test, eSensor thrombophilia risk test, and eSensor warfarin sensitivity test. The company?s other multiplexed molecular diagnostic tests pipeline under development comprise eSensor 2C19 test for the multiplexed detection and genotyping of various alleles of the cytochrome P450 (CYP450) 2C19 gene locus; eSensor re spiratory viral panel, a nucleic acid multiplex test for the simultaneous detection and identification of multiple respiratory virus nucleic acids and mutations that confer resistance of Influenza A to the anti-viral drug Oseltamivir (Tamiflu); and eSensor KRAS/BRAF test for the multiplexed detection and genotyping of 12 mutations in codons 12 and 13 of KRAS and the V600E mutation in BRAF. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.

Advisors’ Opinion:

  • [By Sean Williams]

    What: Shares of GenMark Diagnostics (NASDAQ: GNMK  ) , a molecular diagnostics company, slumped as much as 10% after updating its full-year revenue guidance after the bell last night.

  • [By Roberto Pedone]

    GenMark Diagnostics (GNMK) is a molecular diagnostics company, engages in the development, manufacturing, marketing, sale, and support of instruments and molecular tests based on its proprietary eSensor detection technology in the U.S. This stock closed up 1.7% to $9.89 in Tuesday’s trading session.

    Tuesday’s Range: $9.24-$9.95

    52-Week Range: $6.38-$16.00

    Thursday’s Volume: 562,000

    Three-Month Average Volume: 385,008

    From a technical perspective, GNMK bounced modestly higher here with above-average volume. This stock has been trending sideways inside of a consolidation chart pattern for the last two months, with shares moving between $8.75 on the downside and $10.71 on the upside. This bounce is starting to push GNMK within range of triggering a near-term breakout trade above the upper-end of its sideways trading chart pattern. That breakout will hit if GNMK manages to clear some near-term overhead resistance levels at $10.04 to $10.50 and then once it takes out more resistance at $10.71 with high volume.

    Traders should now look for long-biased trades in GNMK as long as it’s trending above Tuesday’s low of $9.24 or around $9 and then once it sustains a move or close above those breakout levels with volume that hits near or above 385,008 shares. If that breakout triggers soon, then GNMK will set up to re-test or possibly take out its next major overhead resistance levels at $12 to $13.50.

Top Dow Dividend Stocks To Watch For 2015: Pharmacyclics Inc (PCYC)

Pharmacyclics, Inc., incorporated on April 19, 1991, is a clinical-stage biopharmaceutical company focused on developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company’s clinical development and product candidates are small-molecule enzyme inhibitors designed to target biochemical pathways involved in human diseases. As of June 30, 2011, it had three drug candidates under clinical development and a number of preclinical lead molecules. This includes an inhibitor of Bruton’s tyrosine kinase (Btk) (PCI-32765) in Phase II studies in hematologic malignancies; a Btk inhibitor lead optimization program targeting autoimmune indications, an inhibitor of Factor VIIa (PCI-27483) in a Phase II clinical trial in pancreatic cancer, and a histone deacetylase (HDAC) inhibitor (PCI-24781) in Phase I and II clinical trials in solid tumors and hematological malignancies as of June 30, 2012.

As of June 30, 2012, t he Company developed ibrutinib, which has demonstrated clinical activity and tolerability in Phase I and Phase II clinical trials in a variety of B-cell malignancies, including chronic lymphocytic leukemia (CLL) and a number of non-Hodgkin’s lymphoma (NHL) subtypes. CLL, mantle cell lymphoma (MCL), follicular lymphoma (FL), diffuse B-cell lymphoma (DLBCL) and multiple myeloma (MM) are specific indications of its current or planned Phase Ib/II and Phase III development program. had development programs for B-cell malignancies and autoimmune diseases. For malignant indications it has developed PCI-32765, which has demonstrated clinical activity and tolerability in Phase I and Phase II clinical trials in a range of B-cell malignancies, including chronic lymphocytic leukemia (CLL) and a number of non-Hodgkin’s lymphoma (NHL) subtypes. CLL, mantle cell lymphoma (MCL), follicular lymphoma (FL), diffuse large B cell lymphoma (DLBCL) and multiple myeloma (MM) are specific indica tions of its Phase II development. It has developed an assay! to measure occupancy of Btk in PBMCs using a cell-permeable fluorescently-labeled derivative of PCI-32765.

Factor VII is an enzyme that becomes activated (FVIIa) by binding to the cell surface protein tissue factor (TF), a protein found in the body that helps to trigger the process of blood clotting in response to injury. TF is over expressed in many cancers including gastric, breast, colon, lung, prostate, ovarian and pancreatic cancers. In these tumors, the FVIIa/TF complex induces intracellular signaling pathways by activating protease activated receptor 2 (PAR-2), another cell-surface protein. This in turn increases the expression of interleukin-8 (IL-8), a protein produced by white blood cells and other immune cells in response to pathogenic stimulation, and vascular endothelial growth factor (VEGF), a signal protein produced by cells that stimulate the growth of blood vessels. Both proteins play an important role in tumor growth and metastases as well as angiogenesis (growth of new blood vessels). FVIIa/TF complex also initiates the coagulation (a process by which blood forms clots) processes implicated in the high incidence of thromboembolic (the process by which the blood clots within a blood vessel) complications seen in patients with TF-expressing cancers. Thromboembolic events are a cause of death in patients with cancer and anticoagulant treatment has been shown to improve survival in a variety of cancers (Klerk et al. JCO. 2005).

PCI-27483 Factor VIIa Inhibitor

The Company’s Factor VIIa inhibitor PCI-27483 is a first-in-human small molecule inhibitor that selectively targets FVIIa. As an inhibitor of FVIIa, PCI-27483 has two potential mechanisms of action: inhibition of intracellular signaling involved in tumor growth and metastases and inhibition of early coagulation processes associated with thromboembolism.

Factor VIIa PCI-27483 Clinical Development Update

A mu lticenter Phase I/II of PCI-27483 in patients with locally a! dvanced o! r metastatic pancreatic cancer that are either receiving or are planned to receive gemcitabine therapy has completed enrollment. The Phase II portion of the study randomized patients to receive either gemcitabine alone or gemcitabine plus PCI-27483 (1.2 mg/kg twice daily). The objectives are to assess the safety of FVIIa Inhibitor PCI-27483 at pharmacologically active dose levels, to assess potential inhibition of tumor progression and to obtain initial information of the effects on the incidence of thromboembolic events. Due to a paradigm shift away from the use of gemcitabine alone for the treatment of pancreatic cancer, enrolling patients in this randomized study has been challenging. PCYC is evaluating other alternatives for development of this agent.

A multicenter Phase I/II of PCI-27483 in patients with locally advanced or metastatic pancreatic cancer that are either receiving or are planned to receive gemcitabine therapy has completed enrollment. The Phas e II portion of the study randomized patients to receive either gemcitabine alone or gemcitabine plus PCI-27483 (1.2 mg/kg twice daily). PCI-27483 is covered by United States patents and patent applications and counterpart patents and patent applications in fourteen ex-United States territories, including Europe, Canada, Mexico, Japan, China, India, South Korea, Australia and Brazil.

Advisors’ Opinion:

  • [By MONEYMORNING.COM]

    We saw this last year with such Private Briefing recommendations as The Boeing Co. (NYSE: BA) and Pharmacyclics Inc. (Nasdaq: PCYC), which rose more than 100% and 400%, respectively, following our recommendation.

  • [By Ben Levisohn]

    Somaiya and team named Gilead and Neurocrine Biosciences (NBIX) their top picks, hile putting Buy ratings on Celgene, Biogen Idec, Alexion (ALXN), Incyte (INCY), Pharmacyclics (PCYC) and Synageva (GEVA). BioMarin (BMRN), Infinity Pharmaceuticals (INFI) and Amgen (AMGN) earned Neutral ratings.

  • [By John McCamant]

    The company—which we consider conservative among biotech stocks—is Pharmacyclics (PCYC). Its pill is also expected to be approved for a much larger B-cell cancer market, chronic lymphocytic leukemia (CLL), by the end of February.

Top Dow Dividend Stocks To Watch For 2015: Telus Corporation(TU)

TELUS Corporation provides telecommunications products and services primarily in Canada. Its telecommunications products and services include wireless, data, Internet protocol (IP), voice, and television. The company operates through two segments, Wireless and Wireline. The Wireless segment provides digital personal communications, equipment sales, and wireless Internet services. The Wireline segment offers voice local and voice long distance services; data services, which include television, and managed and legacy data services, as well as Internet, enhanced data, and hosting services; and other telecommunications services. TELUS Corporation was founded in 1993 and is based in Burnaby, Canada.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Abbvie (ABBV)
    Ameren Corp. (AEE)
    Arthur J. Gallagher (AJG)
    E.I. DuPont de Nemours & Co. (DD)
    ENSCO (ESV)
    Enterprise Products Partners LP (EPD)
    General Mills (GIS)
    H&R Block (HRB)
    Hancock Holding (HBHC)
    Kraft Foods Group (KRFT)
    Lorillard (LO)
    Magellan Midstream Partners LP (MMP)
    MarkWest Energy Partners L P (MWE)
    McDonald’s (MCD)
    Microchip Technology (MCHP)
    NextEra Energy (NEE)
    Regency Centers (REG)
    TELUS Corp. (TU)
    West Corp. (WSTC)
    Williams Companies (WMB)

  • [By Tom Taulli]

    Big competitors for BCE include Rogers Communications (RCI) and Telus (TU), though it also faces niche players such as Public Mobile, Wind Mobile and Mobilicity. Until recently, there was buzz that Verizon (VZ) might enter the market by buying up the latter two, though VZ apparently scrapped plans for Canadian expansion until 2014.

  • [By Rich Duprey]

    Continuing with its practice of raising its dividend payment every year, Canadian telecom Telus  (NYSE: TU  )  announced today its second-quarter dividend of $0.34 Canadian per share. Last quarter the payout was $0.32 Canadian per share. That’s a 6.25% increase.

  • [By Anders Bylund]

    Last week, Canadian cable company TELUS (NYSE: TU  ) CEO Darren Entwistle said that Netflix might be as much of an opportunity as a competitor. The company could sell rebranded Netflix services under its own banner to get a leg up on its mostly larger head-to-head competitors. Pairing with local cable providers is a strategy that Netflix hasn’t considered (at least not publicly), but it’s a wrinkle that’s worth keeping a watchful eye on.

Top Dow Dividend Stocks To Watch For 2015: Consumer Staples Select Sector SPDR (XLP)

Consumer Staples Select Sector SPDR Fund (the Fund) seeks to provide investment results that correspond to the price and yield performance of the Consumer Staples Select Sector of the S&P 500 Index (the Index). The Index includes companies that are primarily involved in the development and production of consumer products that cover food and drug retailing, beverages, food products, tobacco, household products and personal products.

The Fund utilizes a passive or indexing investment approach to invest in a portfolio of stocks that seek to replicate the Index. The Fund’s investment advisor is SSgA Funds Management, Inc.

Advisors’ Opinion:

  • [By Ben Levisohn]

    The exception to the strong defensive performance: consumer staples. The Consumer Staples Select Sector SPDR (XLP) has dropped 2.9% this year, making it the worst-performing sector in the S&P 500. Barclays’ Barry Knappexplains what’s gone wrong:

  • [By Jon C. Ogg]

    4. Cyclical stocks outperform defensive stocks – This puts consumer discretionary, energy, financials, industrials, technology and materials all doing better than consumer staples, healthcare, telecom, and utilities. Doll also prefers a free cash flow yield to dividend yield and dividend growth over dividend yield.

    ETF Recommendation(s): Financial Select Sector SPDR (NYSEArca: XLF), Technology Select Sector SPDR (NYSEArca: XLK), Market Vectors Oil Services ETF (NYSEArca: OIH)… Avoid Consumer Staples Select Sector SPDR (NYSEArca: XLP) and Utilities Select Sector SPDR (NYSEArca: XLU).

    5. Dividends, stock buy-backs, capex, and M&A all increase at a double-digit rate – This is led by a lot of cash flow, underleveraged balance sheets, and possible great places to use cash. The argument for higher cap-ex is as follows: “Pent-up demand and aging of plant, equipment and technology argue for increases in those key areas.”

  • [By Tom Aspray]

    One of the 3rd quarter’s weakest performers, the Select Sector SPDR Consumer Staples (XLP) has done the best in October as it shows a gain of 7.5% through October 30. The Select Sector SPDR Materials (XLB) was lagging the S&P 500 in the first half of the year, with its small gain of just 2.1%, but rebounded nicely in the 3rd quarter as it was up 9.5%.

Top Dow Dividend Stocks To Watch For 2015: Virginia Mines Inc (VGQ)

Virginia Mines Inc. is engaged in the business of acquiring and exploring mining properties. The Company specializes in searching for gold and base metal deposits in mostly unexplored territories of Quebec. The Company’s properties include Coulon property, Anatacau-Wabamisk project, Lac Pau property, Nichicun property, Trieste property, Ashuanipi property, Baie Payne property and Lac Gayot property. The Anatacau-Wabamisk project is located 30 kilometers southwest of the Opinaca Reservoir, about 290 kilometers north of the town of Matagami, province of Quebec. The Lac Pau property is located in the James Bay region, in the northern part of the Caniapiscau Reservoir, 70 kilometers northeast of the Trans-Taiga Road. The Nichicun property is situated in the central part of the province of Quebec, northwest of the Otish Mountains. The Trieste property is located in the central part of the province of Quebec, to the northwest of the Otish Mountains. Advisors’ Opinion:

  • [By Adrian Day]

    Adrian Day: Yeah, you know, my favorite company in the junior sector remains Virginia Mines, (VGQ) in Toronto, this is, at basis, an exploration company that has built its business by what’s called a prospect generator model, meaning they go out and generate prospects, which they then try to farm out to other people to spend the money.

Top Dow Dividend Stocks To Watch For 2015: Synergy Resources Corp (SYRG)

Synergy Resources Corporation, incorporated on May 11, 2005, is an oil and gas operator in Colorado. The Company is focused on the acquisition, development, exploitation, exploration and production of oil and natural gas properties primarily located in the Denver-Julesburg Basin (D-J Basin) in northeast Colorado. Effective November 13, 2013, Synergy Resources Corp acquired 21 undisclosed oil and gas producing wells, located in Wattenberg Field, Colorado.

As of October 31, 2013, the Company has 374,000 gross and 245,000 net acres under lease, substantially all of which are located in the D-J Basin. Of this acreage, 12,550 gross acres are held by production. In addition to the approximately 22,000 net developed and undeveloped acres that the Company hold in the Wattenberg Field, it hold undeveloped acreage positions in the northern extension area of the D-J Basin, in an area around Yuma County that produces dry gas, and in western Nebraska.

Advisors’ Opinion:

  • [By Value Digger]

    As peers, I selected Artek Exploration (ARKXF.PK), RMP Energy (OEXFF.PK), Synergy Resources (SYRG) and Magnum Hunter Resources (MHR). The first two firms trade also on the main Toronto board under the tickers RTK.TO and RMP.TO respectively. These peers comply with the following criteria:

Top Dow Dividend Stocks To Watch For 2015: Pacific Coast Oil Trust (ROYT)

Pacific Coast Oil Trust is a statutory trust formed by Pacific Coast Energy Company LP (PCEC) to own interests in the Underlying Properties. As of December 31, 2011, the Underlying Properties consisted of the proved developed reserves on the Underlying Properties, which it refers to as the Developed Properties, and all other development potential on the Underlying Properties, which it refers to as the Remaining Properties. The Underlying Properties are located in California in the Santa Maria and Los Angeles Basins. PCEC produces oil and natural gas from its Orcutt properties in the Santa Maria Basin. The production in the Orcutt oilfield is produced from formations utilizing conventional production methods.

PCEC is engaged in the production and development of oil and natural gas from properties located in California. As of December 31, 2011, PCEC held interests in approximately 276 gross (215 net) producing wells, and had proved reserves of approximately 34. 1 million barrels of oil equivalent. The Underlying Properties consist of producing and non-producing interests in oil units, wells and lands located onshore in California in the Santa Maria Basin, which contains PCEC’s Orcutt properties, and the Los Angeles Basin, which contains PCEC’s West Pico, East Coyote and Sawtelle properties. As of December 31, 2011, there were 37 producing wells and six waterflood injection wells in the West Pico Unit. West Pico also includes three wells held by the Stocker JV, a joint venture between PCEC and PXP.

Advisors’ Opinion:

  • [By Rich Duprey]

    Perpetual royalty trust Pacific Coast Oil Trust (NYSE: ROYT  ) announced yesterday its July distribution of $0.15721 per unit. The amount of the trust’s monthly distributions will fluctuate depending on the proceeds it receives from its owner, Pacific Coast Energy, as a result of actual production volumes, oil and gas prices, and development expenses.  The current distribution relates to net profits and overriding royalties generated during May 2013.

  • [By Jake L’Ecuyer]

    Pacific Coast Oil Trust (NYSE: ROYT) down, falling 7.13 percent to $16.70 after the company priced a public offering by Pacific Coast Energy Company LP and other selling unitholders of 13,500,000 trust units at a price of $17.10 per unit.

Top Dow Dividend Stocks To Watch For 2015: First American Financial Corp (FAF)

First American Financial Corporation, incorporated on January 14, 2008, through its subsidiaries, is engaged in the business of providing financial services through its title insurance and services segment and its specialty insurance segment. The Company operates in two segments: title insurance and services and specialty insurance.

The title insurance and services segment provides title insurance, closing and/or escrow services and similar or related services domestically and internationally in connection with residential and commercial real estate transactions. It also maintains, manages and provides access to title plant records and images and provides banking, trust and investment advisory services. The specialty insurance segment issues property and casualty insurance policies and sells home warranty products. In addition, its corporate function consists of certain financing facilities as well as the corporate services that support its business operation s.

Title Insurance and Services Segment

The Company’s title insurance and services segment issues title insurance policies on residential and commercial property in the United States and offers similar or related products and services internationally. This segment also provides closing and/or escrow services; accommodates tax-deferred exchanges of real estate; maintains, manages and provides access to title plant records and images, and provides banking, trust and investment advisory services. The Company conducts its title insurance and closing business through a network of direct operations and agents. Through this network, it issues policies in the 49 states that permit the issuance of title insurance policies and the District of Columbia. The Company also offers title insurance, closing services and similar or related products and services, either directly or through third parties in foreign countries, including Canada, the United Kingdom, A ustralia and various other markets.

The Company! distributes its title insurance policies and related products and services directly as well as through its agents through various channels. Its federal savings bank subsidiary offers trust and investment advisory services, deposit services and asset management services. As of December 31, 2012, the Company provides products and services in numerous countries outside of the United States, and its international operations accounted for approximately 7.9% of its title insurance and services segment revenues

Specialty Insurance Segment

The Company’s property and casualty insurance business provides insurance coverage to residential homeowners and renters for liability losses and typical hazards, such as fire, theft, vandalism and other types of property damage. The Company is licensed to issue policies in all 50 states and the District of Columbia and actively issue policies in 43 states. In its market, California, it also offers preferred risk aut o insurance to better compete with other carriers offering bundled home and auto insurance. Reinsurance is used to limit risk associated with natural disasters, such as windstorms, winter storms, wildfires and earthquakes.

The Company’s home warranty business provides residential service contracts that cover residential systems, such as heating and air conditioning systems, and certain appliances against failures that occur as the result of normal usage during the coverage period. Most of these policies are issued on resale residences, although policies are also available in some instances for new homes. Coverage is typically for one year and is renewable annually at the option of the contract holder and upon its approval. It sells renewals directly to consumers. As of December 31, 2012, home warranty business operates in 39 states and the District of Columbia.

The Company competes with Fidelity National Financial, Inc., Stewart Title Guaranty Com pany, Old Republic International Corporation and Lender Proc! essing Se! rvices, Inc.

Advisors’ Opinion:

  • [By alicet236]

    First American Financial Corp (FAF): CEO Dennis J Gilmore sold 116,453 Shares

    CEO of First American Financial Corp (FAF) Dennis J Gilmore sold 116,453 shares on 02/04/2014 at an average price of $25.12. First American Financial Corporation was incorporated in the state of Delaware in January 2008 to serve as the holding company of The First American Corporation’s financial services business. First American Financial Corp has a market cap of $2.7 billion; its shares were traded at around $25.52 with a P/E ratio of 12.30 and P/S ratio of 0.56. The dividend yield of First American Financial Corp stocks is 1.88%.

  • [By Canadian Value]

    Position % of Fund Assets 1) First American Financial Corp. (FAF) 7.0% 2) Apple, Inc. (AAPL) 6.5% 3) Coinstar, Inc. (CSTR) 4.8% 4) EMC Corp. (EMC) 4.4% 5) Coach, Inc. (COH) 4.4% 6) Kohl’s Corp. (KSS) 4.1% 7) Blucora, Inc. (BCOR) 4.0% 8) Tetra Tech, Inc. (TTEK) 3.1% 9) OM Group, Inc. (OMG) 3.0% 10) American International Group, Inc. (AIG) 2.8% TOTAL 44.1% One area that we believe still offers some value in the market is in high quality, large‐cap technology stocks that may be momentarily out‐of‐favor as they transition from rapid growth to slower growth. In particular, we become interested when that transition is also accompanied by a change in capital allocation policies designed to return more cash to shareholders in the form of dividends and share repurchases. We believe that Apple and EMC are two of the absolute highest quality technology businesses in the world and both have recently announced very material, shareholder‐ friendly changes to how they will alloc ate capital.

  • [By Jon C. Ogg]

    First American Financial Corp. (NYSE: FAF) was raised to Outperform from Market Perform at Keefe Bruyette & Woods.

    Fidelity National Financial Inc. (NYSE: FNF) was raised to Outperform from Market Perform at Keefe Bruyette & Woods.

Top Dow Dividend Stocks To Watch For 2015: American Public Education Inc.(APEI)

American Public Education, Inc., together with its subsidiary, American Public University System, Inc., provides online postsecondary education focusing on the needs of the military and public service communities. The company operates through two universities, American Military University (AMU) and American Public University (APU) serving approximately 110,000 students in the United States and internationally. The universities share a common faculty and curriculum, which includes 87 degree programs and 69 certificate programs in disciplines related to national security, military studies, intelligence, homeland security, criminal justice, technology, business administration, education, nursing, and liberal arts. The company was founded in 1991 and is headquartered in Charles Town, West Virginia.

Advisors’ Opinion:

  • [By James Brumley]

    American Public Education (APEI) has been one of the biggest victims of the DOE’s partial shutdown. The 41,000 individual online classes scheduled to begin a few days ago were reduced by 13,000 when many military and government employees lost their tuition assistance as of October 1st.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on American Public Education (Nasdaq: APEI  ) , whose recent revenue and earnings are plotted below.

Top Dow Dividend Stocks To Watch For 2015: Petroleo Brasileiro Petrobras SA (PETR3)

Petroleo Brasileiro SA Petrobras (Petrobras) is a Brazil-based integrated oil and gas company. The Company divides its activities into seven segments: Exploration and Production; Refining, Transportation and Marketing; Gas and Power; Biofuel; Distribution and International. Directly or through its subsidiaries, Petrobras is engaged in the research, extraction, refining, processing, trade and transport of oil from wells, shale and other rocks, its derivatives, natural gas and other liquid hydrocarbons, as well as in activities related to energy, development, production, transport, distribution and commercialization of energy. The Company’s offering comprises road transportation products such as Automotive Gasoline, Diesel Fuel, Natural Vehicular Gas, Lubrax; agriculture and cattle raising products such as Sunflower Meal, among others; Industrial products such as Solvents and Paraffins, among others. The Company provides its services both for individual and business clients. Advisors’ Opinion:

  • [By Maria Levitov]

    Brazil’s Ibovespa advanced amid speculation that a three-session slump for Brazil’s benchmark equity index was excessive. Usiminas, as Usinas de Minas Gerais is known, rose 7.5 percent, while oil company Petroleo Brasileiro SA (PETR3) contributed the most to the gauge’s advance.

  • [By Julia Leite]

    Brazil’s Ibovespa rose 1.2 percent, reversing a decline of as much as 0.9 percent, as Petroleo Brasileiro SA (PETR3), Brazil’s state-run crude producer, surged. The real added 1.5 percent.